Although the treatment of myeloma has changed dramatically after the readout of many recent trials, key unanswered questions ...

After being diagnosed with multiple myeloma, Valarie Traynham turned her journey into a mission—raising awareness, educating ...

Saad Usmani, Chief of MSK's Myeloma Service, says there are far more treatment options for multiple myeloma today compared with just 20 years ago. Note: This story was originally published in 2022 and ...

GSK continues to build the case for its multiple myeloma therapy Blenrep ... drug has been associated with side effects, particularly eye toxicity, that some analysts believe could limit its ...

Follow along on our guide to Multiple Myeloma, a cancer of the bone marrow's infection-fighting plasma cells. As cancerous ...

The FDA has approved GlaxoSmithKline’s multiple myeloma drug Blenrep ... corneal ulcer and symptoms such as blurred vision and dry eyes. Ocular adverse reactions occurred in 77% of the 218 ...

Pomalyst (pomalidomide) is a prescription drug that’s used to treat multiple myeloma in adults. Pomalyst is also available as a generic drug. Pomalyst comes as an oral capsule. The active ...

A longitudinal multiomics analysis of a patient with multiple myeloma who developed peripheral T cell lymphoma after treatment with anti-BCMA CAR T cells and a GPRC5D-directed bispecific antibody ...

In a Community Case Forum in partnership with the North Carolina Oncology Association, Cristina Gasparetto, MD, discussed the CEPHEUS, IMROZ, and BENEFIT trials of treatment for transplant-ineligible ...